Related references
Note: Only part of the references are listed.Time Trends for Prostate Cancer Incidence from 2003 to 2013 in South Korea: An Age-Period-Cohort Analysis
Hyun Young Lee et al.
CANCER RESEARCH AND TREATMENT (2020)
Urological symptoms among 23,240 men in the general danish population - concerns about symptoms, their persistence and influence on primary care contacts
Majken Solvang et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2018)
Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer A Meta-Analysis of Observational Studies
Xiaoyu Dai et al.
MEDICINE (2016)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System
Sun Ok Song et al.
DIABETES & METABOLISM JOURNAL (2014)
Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan
Chin-Hsiao Tseng
BMC CANCER (2013)
Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
S-C Hung et al.
BRITISH JOURNAL OF CANCER (2013)
OPINION The link between benign prostatic hyperplasia and prostate cancer
David D. Orsted et al.
NATURE REVIEWS UROLOGY (2013)
The Role of Prostatitis in Prostate Cancer: Meta-Analysis
Junyi Jiang et al.
PLOS ONE (2013)
Prostate cancer and inflammation: the evidence
Karen S. Sfanos et al.
HISTOPATHOLOGY (2012)
East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians
Tomomi Kimura
CHINESE JOURNAL OF CANCER (2012)
Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
The economic burden of prostate cancer
Claus G. Roehrborn et al.
BJU INTERNATIONAL (2011)
Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men
David D. Orsted et al.
EUROPEAN UROLOGY (2011)
Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates
Pallavi Lonkar et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Systematic review of human papillomavirus prevalence in invasive penile cancer
Danielle M. Backes et al.
CANCER CAUSES & CONTROL (2009)
Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
Antonio Alcaraz et al.
EUROPEAN UROLOGY (2009)
The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
Helmut Bonkhoff et al.
EUROPEAN UROLOGY (2009)
Epidemiology of prostatitis
John N. Krieger et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
The role of inflammation and infection in the pathogenesis of prostate carcinoma
Florian M. E. Wagenlehner et al.
BJU INTERNATIONAL (2007)
The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia
Cuneyt Ozden et al.
EUROPEAN UROLOGY (2007)
The influence of chronic inflammation in prostatic carcinogenesis: A 5-year followup study
Gregory T. MacLennan et al.
JOURNAL OF UROLOGY (2006)
Rising prostate cancer rates in South Korea
Sue Kyung Park et al.
PROSTATE (2006)
Evolution of the androgen receptor pathway during progression of prostate cancer
Peter J. M. Hendriksen et al.
CANCER RESEARCH (2006)
Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia -: A population-based cohort study in Sweden
AP Chokkalingam et al.
CANCER (2003)
Share Paper
